Market Closed -
Nasdaq
04:00:00 2024-07-05 pm EDT
|
5-day change
|
1st Jan Change
|
6.34
USD
|
-2.31%
|
|
-1.71%
|
+24.07%
|
Fiscal Period: Marzo |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
7,154
|
15,424
|
3,737
|
1,215
|
1,062
|
658.3
|
-
|
-
|
Enterprise Value (EV)
1 |
5,643
|
14,708
|
3,866
|
1,739
|
1,456
|
1,282
|
1,465
|
1,676
|
P/E ratio
|
-5.38
x
|
-8.61
x
|
-12.3
x
|
-0.34
x
|
-1.33
x
|
-5.2
x
|
-6.95
x
|
-7.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.9
x
|
28.2
x
|
7.18
x
|
3.02
x
|
3.09
x
|
2.17
x
|
2.02
x
|
1.8
x
|
EV / Revenue
|
14.2
x
|
26.9
x
|
7.43
x
|
4.32
x
|
4.23
x
|
4.23
x
|
4.51
x
|
4.57
x
|
EV / EBITDA
|
-12.7
x
|
-43.2
x
|
-9.31
x
|
-4.97
x
|
-24.7
x
|
-151
x
|
67.2
x
|
28.5
x
|
EV / FCF
|
-3.82
x
|
-23.3
x
|
-6.64
x
|
-3.07
x
|
-5.1
x
|
-9.86
x
|
-20.5
x
|
-82
x
|
FCF Yield
|
-26.2%
|
-4.28%
|
-15.1%
|
-32.6%
|
-19.6%
|
-10.1%
|
-4.87%
|
-1.22%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
34,965
|
38,216
|
39,417
|
51,264
|
91,115
|
76,198
|
-
|
-
|
Reference price
2 |
204.6
|
403.6
|
94.80
|
23.70
|
11.66
|
8.640
|
8.640
|
8.640
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
398.8
|
546.6
|
520.3
|
402.9
|
343.9
|
302.9
|
325.1
|
366.8
|
EBITDA
1 |
-442.8
|
-340.3
|
-415.4
|
-349.7
|
-58.92
|
-8.481
|
21.79
|
58.77
|
EBIT
1 |
-1,046
|
-1,134
|
-713.3
|
-2,848
|
-228.7
|
-90.87
|
-60.58
|
-25.86
|
Operating Margin
|
-262.23%
|
-207.44%
|
-137.09%
|
-706.94%
|
-66.5%
|
-30%
|
-18.63%
|
-7.05%
|
Earnings before Tax (EBT)
1 |
-1,509
|
-1,684
|
-329.4
|
-3,314
|
-471.4
|
-154
|
-113.4
|
-79.47
|
Net income
1 |
-1,321
|
-1,745
|
-302.2
|
-3,278
|
-657.3
|
-134.7
|
-115.3
|
-94.37
|
Net margin
|
-331.35%
|
-319.2%
|
-58.08%
|
-813.63%
|
-191.1%
|
-44.48%
|
-35.46%
|
-25.73%
|
EPS
2 |
-38.00
|
-46.90
|
-7.700
|
-70.70
|
-8.790
|
-1.662
|
-1.243
|
-1.113
|
Free Cash Flow
1 |
-1,478
|
-630.2
|
-582.5
|
-566.8
|
-285.4
|
-130.1
|
-71.39
|
-20.43
|
FCF margin
|
-370.53%
|
-115.29%
|
-111.95%
|
-140.67%
|
-82.98%
|
-42.94%
|
-21.96%
|
-5.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
2026 Q1
|
---|
Net sales
1 |
141
|
111.8
|
110.1
|
117.9
|
101.2
|
87.54
|
108.7
|
69.6
|
90.06
|
83.15
|
73.22
|
70.25
|
77.32
|
79.4
|
77.5
|
EBITDA
1 |
-67.41
|
-121.8
|
-74.8
|
-78.1
|
-87.5
|
-95.64
|
-57.84
|
-11.86
|
-8.989
|
-15.09
|
-7.207
|
-4.43
|
0.4945
|
3.911
|
-
|
EBIT
1 |
-150
|
-288.5
|
-110.2
|
-175.8
|
-153.8
|
-604.7
|
-87.48
|
-36.9
|
-60.32
|
-106.7
|
-25.63
|
-22.39
|
-17.4
|
-14.09
|
-
|
Operating Margin
|
-106.38%
|
-258.12%
|
-100.12%
|
-149.2%
|
-151.92%
|
-690.82%
|
-80.45%
|
-53.02%
|
-66.97%
|
-128.36%
|
-35%
|
-31.87%
|
-22.5%
|
-17.74%
|
-
|
Earnings before Tax (EBT)
1 |
-115.7
|
-587.1
|
-2,084
|
-223.7
|
-267.1
|
-664
|
-39.84
|
-135.3
|
-231.4
|
-96.11
|
-41.95
|
-38.1
|
-32.7
|
-28.68
|
-
|
Net income
1 |
-108.9
|
-574.6
|
-2,083
|
-221.8
|
-261.6
|
-640.1
|
-38.12
|
-310
|
-216.8
|
-82.34
|
-37.29
|
-34
|
-29.76
|
-22.51
|
-
|
Net margin
|
-77.27%
|
-514.11%
|
-1,891.79%
|
-188.19%
|
-258.45%
|
-731.23%
|
-35.06%
|
-445.45%
|
-240.72%
|
-99.02%
|
-50.93%
|
-48.39%
|
-38.5%
|
-28.35%
|
-
|
EPS
2 |
-2.800
|
-14.60
|
-52.30
|
-4.700
|
-5.400
|
-12.80
|
-0.7000
|
-4.300
|
-2.620
|
-1.030
|
-0.4880
|
-0.4400
|
-0.3720
|
-0.3020
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/22
|
5/27/22
|
8/5/22
|
11/9/22
|
2/9/23
|
6/22/23
|
8/9/23
|
11/9/23
|
2/9/24
|
5/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
129
|
524
|
394
|
624
|
807
|
1,018
|
Net Cash position
1 |
1,511
|
716
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.3113
x
|
-1.499
x
|
-6.683
x
|
-73.58
x
|
37.03
x
|
17.32
x
|
Free Cash Flow
1 |
-1,478
|
-630
|
-582
|
-567
|
-285
|
-130
|
-71.4
|
-20.4
|
ROE (net income / shareholders' equity)
|
-21.7%
|
-27.3%
|
-8.55%
|
-151%
|
-104%
|
-36.7%
|
-82%
|
-643%
|
ROA (Net income/ Total Assets)
|
-17.1%
|
-17.2%
|
-4.86%
|
-81.5%
|
-35.1%
|
-12.6%
|
-12.9%
|
-12.8%
|
Assets
1 |
7,711
|
10,167
|
6,219
|
4,022
|
1,870
|
1,069
|
893.9
|
737.2
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-22.20
|
-12.50
|
-
|
-12.00
|
-3.770
|
1.470
|
0.7900
|
0.1400
|
Capex
1 |
705
|
165
|
36.7
|
9.22
|
3.45
|
5.98
|
6.86
|
10.9
|
Capex / Sales
|
176.78%
|
30.09%
|
7.05%
|
2.29%
|
1%
|
1.97%
|
2.11%
|
2.97%
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Last Close Price
8.64
CAD Average target price
9.236
CAD Spread / Average Target +6.90% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.19% | 5.56B | | -33.59% | 3.52B | | -2.97% | 3.01B | | -24.21% | 2.65B | | -10.11% | 2.3B | | +43.66% | 1.91B | | +46.15% | 1.5B | | -13.92% | 1.41B | | +41.90% | 1.37B |
Alternative Medicine
|